ContextVision AB (publ) (OSL:CONTX)
Norway
· Delayed Price · Currency is NOK | Market Cap | 273.91M |
| Revenue (ttm) | 121.39M |
| Net Income (ttm) | 860.72K |
| Shares Out | 74.64M |
| EPS (ttm) | 0.01 |
| PE Ratio | 318.24 |
| Forward PE | 34.62 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,315 |
| Average Volume | 54,785 |
| Open | 3.690 |
| Previous Close | 3.640 |
| Day's Range | 3.670 - 3.690 |
| 52-Week Range | 2.700 - 6.350 |
| Beta | 0.18 |
| RSI | 63.30 |
| Earnings Date | Apr 8, 2026 |
About ContextVision AB
ContextVision AB (publ), a software company, provides image analysis and imaging for medical systems in South Korea, China, Japan, the United States, and internationally. The company offers image quality solutions for ultrasound, as well as its Rivent platform comprising Rivent, a 2D image enhancement; Rivent Plus, a premium 2D image enhancement product; Rivent 3D, a solution for improving image quality of 3D ultrasound; and Rivent Mobile, a 2D image enhancement for handheld devices for diagnostics in various fields, including radiology, cardio... [Read more]
Financial Performance
In 2025, ContextVision AB's revenue was 110.99 million, a decrease of -15.17% compared to the previous year's 130.84 million. Earnings were 787,000, a decrease of -96.81%.
Financial numbers in SEK Financial StatementsNews
ContextVision AB (LTS:0L8Z) Q4 2025 Earnings Call Highlights: Navigating Challenges with ...
ContextVision AB (LTS:0L8Z) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic Innovations
Q4 2025 ContextVision AB Earnings Call Transcript
Q4 2025 ContextVision AB Earnings Call Transcript
ContextVision AB Earnings Call Transcript: Q4 2025
Transformation to quantitative imaging progressed, with new clinical products launched and first patient enrolled in a data quality study. Q4 revenue declined 7.3% year-over-year due to FX, but market stabilization and a strong cash position support continued investment.
What To Expect From ContextVision AB (OSL:CONTX) Q4 2025 Earnings
What To Expect From ContextVision AB (OSL:CONTX) Q4 2025 Earnings
ContextVision AB (OSL:CONTX) Q3 2025 Earnings Call Highlights: Strategic Initiatives Amid ...
ContextVision AB (OSL:CONTX) Q3 2025 Earnings Call Highlights: Strategic Initiatives Amid Revenue Challenges
Q3 2025 ContextVision AB Earnings Call Transcript
Q3 2025 ContextVision AB Earnings Call Transcript
ContextVision AB Earnings Call Transcript: Q3 2025
Revenue declined 21% year-over-year in Q3 due to market headwinds and FX impacts, but strategic progress continued in both Image and Data Quality. Strong cash position and new product launches support confidence in long-term growth.
ContextVision AB Earnings Call Transcript: Q2 2025
Q2 2025 saw a 10% revenue decline to SEK 28.6 million, impacted by FX headwinds and market uncertainty. Key milestones included new partnerships, a major software upgrade, and a strong cash position of SEK 70 million, supporting continued investment and product launches.
ContextVision AB Earnings Call Transcript: Q1 2025
Revenue fell 24% year-over-year to SEK 26.3 million, with adjusted EBITDA at SEK 2.1 million and a strong cash position of SEK 70 million. Key milestones include a major partnership with the University of Washington and expanded collaborations in data and image quality.
ContextVision AB Earnings Call Transcript: Q4 2024
Q4 delivered record revenue and strong EBITDA margin, driven by new product launches and OEM collaborations. A share buyback and a new partnership with the University of Washington highlight strategic moves, while a robust cash position supports future growth.
ContextVision AB Earnings Call Transcript: Q3 2024
Q3 2024 saw net sales decline 8.1% year-over-year to SEK 30.1 million, mainly due to last year's non-recurring sales, while adjusted EBITDA margin remained strong at 37.9%. Investments in product development and organizational growth continue, with a key partnership expected by year-end.
ContextVision AB Earnings Call Transcript: Q2 2024
Q2 net sales reached SEK 31.7 million with a 6% year-over-year decline, but recurring license revenue showed organic growth. Strategic investments in POCUS and new customer wins in Asia and North America support a stable outlook, with a strong cash position enabling continued expansion.